EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea

Hyeong In Ha iD, Ji Hyun Kim iD, Jiwon Lim iD, Yong Jung Song iD, Young-Joo Won iD, Myong Cheol Lim iD

Journal of Gynecologic Oncology · 2024

DOI: 10.3802/jgo.2024.35.e31 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Hyeong In Ha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinosarcoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NRF, Pusan National University Yangsan Hospital, National Cancer Center of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the incidence and survival outcomes of ovarian carcinosarcoma in Korea between 1999 and 2018. METHODS: Patients diagnosed with ovarian carcinosarcoma between 1999 and 2018 were identified from the Korea Central Cancer Registry (KCCR) and their information was collected. Age-standardized incidence rates (ASRs), annual percent changes (APC), and relative survival rates of ovarian carcinosarcoma were calculated and compared to those of epithelial ovarian cancer. RESULTS: According to the KCCR, 458 cases of ovarian carcinosarcoma were detected, and accounted for 1.5% (458/30,679) of all epithelial ovarian cancers in Korea between 1999 and 2018. The ASR of ovarian carcinosarcoma between 1999 and 2018 was 0.064 per 100,000 women. The incidence rate of ovarian carcinosarcoma increased during the study period, with an ASR of 0.029 per 100,000 in 1999 and 0.073 per 100,000 in 2018. The APC of ovarian carcinosarcoma during 1999-2018 was 5.86 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCarcinosarcomaHumansFemaleIncidenceTreatment OutcomeCarcinoma, Ovarian EpithelialRegistriesRepublic of KoreaSurvival Rate

Stichwörter der Autor:innen

CarcinosarcomaOvarian Cancer

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, Korea.
  • Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
  • Division of Health Administration, Yonsei University, Wonju, Korea. astra67@ncc.re.kr.
  • Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
  • Center for Clinical Trials, Hospital and Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea. mclim@ncc.re.kr.

ORCID-Profile: Hyeong In Ha, Ji Hyun Kim, Jiwon Lim, Yong Jung Song, Young-Joo Won, Myong Cheol Lim

Förderung

  • NRF
  • Pusan National University Yangsan Hospital
  • National Cancer Center of Korea
  • National Research Foundation of Korea

Zitieren

APA

Ha, H. I., Kim, J. H., Lim, J., Song, Y. J., Won, Y. J., & Lim, M. C. (2024). Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2024.35.e31

Vancouver

Ha HI, Kim JH, Lim J, Song YJ, Won YJ, Lim MC. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea. Journal of Gynecologic Oncology. 2024. doi:10.3802/jgo.2024.35.e31

BibTeX
@article{Ha2024,
  author = {Ha, Hyeong In and Kim, Ji Hyun and Lim, Jiwon and Song, Yong Jung and Won, Young-Joo and Lim, Myong Cheol},
  title = {Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea},
  journal = {Journal of Gynecologic Oncology},
  year = {2024},
  doi = {10.3802/jgo.2024.35.e31}
}
Kostenlos starten →